BRCA1 and breast cancer: Over 60% were diagnosed at Stage I (30.2%) or II (31.7%); 64.8% did not know their breast cancer subtype; and 64.4% did not know their breast cancer susceptibility gene mutation (BRCA1 or BRCA2) carrier status.